Skip to content
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Menu
Home
Team
Healthcare
Patient-First Statement
Pipeline
Invest
Investor Hub
Corporate Governance
Shareholder Communications
News
Contact
Sara Polanski
May 10, 2023
Study finds Medicinal Cannabis May Have Impact on Quality of Life
April 24, 2023
Emyria Unveils Highest Potency CBD Capsule for FDA Pathway
April 17, 2023
Emyria to Develop Psilocybin Therapy Care Model
April 3, 2023
Aspen Australia & Emyria Agreement for EMD-RX5
March 22, 2023
Strong Recruitment for EMD-RX5 Phase 3 Trial
March 19, 2023
MDMA Analogue Library Expands to Address Mental Health Disorders
March 6, 2023
Emyria partners with Pax Centre for MDMA-assisted therapy
March 2, 2023
Blog: A Passion for Building Companies That Aim to Do Good
February 27, 2023
Emyria releases Half-Yearly Report
February 6, 2023
Emyria to expand MDMA programs following landmark TGA decision
Load More
Search
Search
Search
ASX News
General News
Publications
Thought Leadership
Uncategorised